Advancing Arthritis Research Through Open Access
Join a global community of rheumatologists, orthopedic researchers, immunologists, and clinical scientists accelerating breakthroughs in arthritis understanding and treatment. Membership provides predictable publishing costs, expert editorial support, and worldwide visibility for your musculoskeletal research.
About the Journal
The Journal of Arthritis Research and Therapy is a peer-reviewed, open access publication dedicated to publishing original research, clinical studies, reviews, and case reports on all aspects of arthritis and rheumatic diseases. Our scope includes rheumatoid arthritis, osteoarthritis, psoriatic arthritis, juvenile idiopathic arthritis, gout, lupus, spondyloarthropathies, and related autoimmune and inflammatory conditions affecting joints and connective tissues.
Our editorial board includes distinguished rheumatologists, orthopedic surgeons, immunologists, and research scientists from leading medical centers worldwide. We welcome clinical trials, translational research, basic science investigations, epidemiological studies, and therapeutic outcome research that advances understanding of disease mechanisms, diagnostic approaches, and treatment strategies for patients with arthritis and related conditions.
We maintain rigorous ethical and methodological standards for all submissions. Authors must provide institutional ethics approvals, informed consent documentation, transparent conflict of interest disclosures, and complete data availability statements. We encourage adherence to CONSORT for randomized trials, PRISMA for systematic reviews, and STROBE for observational studies. Membership never influences editorial decisions; all manuscripts undergo identical expert peer review.
Research Scope
Rheumatoid arthritis, osteoarthritis, psoriatic arthritis, juvenile idiopathic arthritis, gouty arthritis, lupus, and autoimmune inflammatory diseases
Article Types
Clinical trials, systematic reviews, case reports, translational research, epidemiological studies, and basic science investigations
Expert Review
Board-certified rheumatology specialists who understand complex autoimmune disease mechanisms and therapeutic interventions
Why Researchers Choose Membership
Publishing arthritis research should accelerate patient care improvements, not create financial stress or publication uncertainty. The rheumatology field faces unique challenges in scholarly publishing that our membership program directly addresses. Many researchers struggle with unpredictable publication costs that complicate grant budgeting, long review cycles that delay sharing findings with treating physicians, and limited visibility when research remains behind paywalls inaccessible to clinical practitioners. Our membership program eliminates these barriers with predictable annual costs, expert rheumatology reviewers, and full open access publication reaching clinicians worldwide.
Eliminate Cost Uncertainty
Accelerate Publication
Reach Clinical Practitioners
Rigorous Expert Review
Membership Tiers
Select the tier that matches your publication volume and career stage. Whether you are an individual rheumatology investigator conducting clinical or translational research, a graduate student developing expertise in autoimmune disease mechanisms, an academic rheumatology department supporting multiple faculty researchers, or a pharmaceutical company developing novel arthritis therapeutics and biologics, our membership tiers provide meaningful cost savings and dedicated author support throughout the entire publication lifecycle from initial submission through final publication.
Individual Researcher
$5,400/yr $2,970 per year- Unlimited submissions
- 30% special issue discount
- Author/co-author eligible
- Editorial guidance
- Membership certificate
- 2-year option: $3,465
Student
$3,200/yr $2,080 per year- Unlimited submissions
- Primary/co-author eligible
- CV certificate
- Compliance guidance
- Requires advisor letter
- 2-year option: $2,405
Institutional
$9,500 per year- 20 manuscripts APC waiver
- Departmental sharing
- Centralized billing
- Platform recognition
- Onboarding support
- 2-year: $11,500 (30)
Corporate
$5,600/yr $3,640 for 10 articles- 10 staff manuscripts/year
- Themed issue contributions
- Recognition certificate
- Same review standards
- Stakeholder recognition
- 2-year: $4,225 (15/yr)
Submit Your Research
Two convenient pathways to share your arthritis research with the global rheumatology and clinical medicine community.
How to Apply
Ready to join the growing community of rheumatology researchers benefiting from membership? Email info@openaccesspub.org to begin your membership application. Our dedicated team responds within 48 hours with detailed next steps and pricing confirmation for your selected tier.
Contact Us
Send your name, institutional affiliation, and desired membership tier
Confirm Details
We verify eligibility and confirm final pricing details
Complete Payment
Secure invoice processing with flexible payment methods
Start Publishing
Submit your manuscripts with all membership benefits fully active
Important Terms
Membership benefits apply during active term and do not roll over unless specified in writing.
Early renewal before expiration qualifies for a 20% discount on renewal fees.
APC relief applies after peer review and formal acceptance, not upon submission.
Membership does not guarantee acceptance; all manuscripts undergo standard expert review.
Editorial Independence: Membership reduces publication costs but never influences peer review outcomes or acceptance decisions. Every manuscript submitted to our journal is evaluated on scientific merit and methodological rigor alone. The editorial team and peer reviewers operate independently from membership administration, ensuring objective evaluation of all submissions regardless of author membership status.
Common Questions
No. APC waivers and membership benefits apply only to manuscripts that successfully complete the full peer review process and receive formal acceptance from our rheumatology editorial team. Rejected manuscripts do not count against your benefits.
Yes. All co-authors listed on your manuscripts receive full APC relief within your membership allowance, making multi-author collaboration cost-effective and straightforward for research teams.
Unlimited submission benefits exclude special issues, but members receive a generous 30% discount on all special issue APCs.
Absolutely. Contact our dedicated membership team anytime to upgrade your tier and receive a revised agreement reflecting your new benefits and enhanced support options.
Advance Arthritis Research Today
Remove publication barriers. Reach clinicians, researchers, and patients worldwide. Accelerate breakthroughs in joint health, inflammatory disease understanding, and patient care.